Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Detalles Bibliográficos
Autores principales: Chen, Z, Wang, W, Cortes, J E, Liu, E, Miranda, R N, Zhao, C, Yuan, J, Lu, X, Yang, W, Ameri, M D, Kantarjian, H M, Medeiros, L J, Hu, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916296/
https://www.ncbi.nlm.nih.gov/pubmed/27152845
http://dx.doi.org/10.1038/bcj.2016.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916296/
https://www.ncbi.nlm.nih.gov/pubmed/27152845
http://dx.doi.org/10.1038/bcj.2016.27

Ejemplares similares